EVOFEM BIOSCIENCES, INC. (EVFM) Operating income 2016–2025
EVOFEM BIOSCIENCES, INC. (EVFM) annual operating income history from SEC filings — each fiscal year as reported.
$3.4MFY2025 · since FY2016: -$12.0M → $3.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.4M | +143.9% |
| FY2024 | -$7.7M | +57.0% |
| FY2023 | -$17.8M | +78.8% |
| FY2022 | -$84.1M | +49.6% |
| FY2021 | -$166.8M | -61.0% |
| FY2020 | -$103.6M | -96.5% |
| FY2019 | -$52.7M | +32.1% |
| FY2018 | -$77.6M | -117.6% |
| FY2017 | -$35.7M | -196.3% |
| FY2016 | -$12.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EVFM financial trends
EVFM RevenueEVFM Net incomeEVFM Net marginEVFM Gross profitEVFM Gross marginEVFM Operating marginEVFM Operating cash flowEVFM Free cash flowEVFM Capital expendituresEVFM Return on equityEVFM Stock buybacksEVFM Dividends paidEVFM Total assetsEVFM Total liabilitiesEVFM Shareholders’ equityEVFM overview →